Dr. Bottsford-Miller is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
801 N 29th St
Billings, MT 59101Phone+1 406-238-2500
Education & Training
- University of North Carolina HospitalsResidency, Obstetrics and Gynecology, 2006 - 2010
- University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 2006
- University of Texas M D Anderson Cancer CenterFellowship, Gynecologic Oncology
Certifications & Licensure
- MT State Medical License 2014 - 2026
- WI State Medical License 2023 - 2025
- ND State Medical License 2019 - 2024
- WY State Medical License 2018 - 2023
- TX State Medical License 2012 - 2016
- NC State Medical License 2006 - 2010
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Publications & Presentations
PubMed
- Multi-Institutional Study of Referral Patterns for Gynecologic Oncology Consultation.Joseph A DeMari, Isheeta Madeka, Joni K Evans, Courtney Bailey, Kristen Bartucci
JCO Oncology Practice. 2024-09-01 - 16 citationsProof of principle study of sequential combination atezolizumab and Vigil in relapsed ovarian cancerRodney P. Rocconi, Erin E. Stevens, Justin N. Bottsford-Miller, Sharad A. Ghamande, Jeffrey Elder
Cancer Gene Therapy. 2021-03-22 - 72 citationsGemogenovatucel-T (Vigil) immunotherapy as maintenance in frontline stage III/IV ovarian cancer (VITAL): a randomised, double-blind, placebo-controlled, phase 2b trial.Rodney P. Rocconi, Elizabeth A. Grosen, Sharad A. Ghamande, John K. Chan, Minal A. Barve
The Lancet. Oncology. 2020-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: